Koyfin Home > Directory > Health Care > Boston Scientific Corp > Gross Margin

Boston Scientific Corp Gross Margin Chart (BSX)

Boston Scientific Corp annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Boston Scientific Corp Gross Margin for the quarter ending September 09, 2020 was $67m a -8.87% decrease of -6m year over year
  • Boston Scientific Corp Gross Margin for the last 12 months ending September 09, 2020 was $67m a -5.35% decrease of -4m year over year
  • Boston Scientific Corp Annual Gross Margin for 2019 was $71m a -0.13% decrease of 0m from 2018
  • Boston Scientific Corp Annual Gross Margin for 2018 was $71m a -0.01% decrease of 0m from 2017
  • Boston Scientific Corp Annual Gross Margin for 2017 was $71m a 0.53% increase of 0m from 2016
Other Margins & Efficiency Metrics:
  • Boston Scientific Corp EBITDA Margin for the quarter ending December 12, 2018 was $28m a 2.12% increase of 1m year over year
  • Boston Scientific Corp Return on Capital % for the quarter ending December 12, 2018 was 8.25 a -5.41% decrease of -0.45 year over year
  • Boston Scientific Corp Return on Equity % for the quarter ending December 12, 2018 was 18.63 a 8.85% increase of 1.65 year over year
View Chart On Koyfin

Quarterly BSX Gross Margin Data

09/2020$67m
06/2020$60m
03/2020$68m
12/2019$73m
09/2019$71m
06/2019$71m
03/2019$70m
12/2018$73m
09/2018$71m
06/2018$70m

Annual BSX Gross Margin Data

2019$71m
2018$71m
2017$71m
2016$71m
2015$71m
2014$70m
2013$68m
2012$66m
2011$63m
2010$65m